793 related articles for article (PubMed ID: 11602409)
1. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
2. Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Peddie CM; Bowen DT; Pippard MJ
Leukemia; 2002 May; 16(5):785-90. PubMed ID: 11986938
[TBL] [Abstract][Full Text] [Related]
3. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
Gidáli J; Fehér I; Hollán SR
Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
5. Importance of parenchymal:stromal cell ratio for the ex vivo reconstitution of human hematopoiesis.
Koller MR; Manchel I; Palsson BO
Stem Cells; 1997; 15(4):305-13. PubMed ID: 9253115
[TBL] [Abstract][Full Text] [Related]
6. Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome.
Narendran A; Hawkins LM; Ganjavi H; Vanek W; Gee MF; Barlow JW; Johnson G; Malkin D; Freedman MH
Pediatr Hematol Oncol; 2004; 21(3):209-21. PubMed ID: 15202160
[TBL] [Abstract][Full Text] [Related]
7. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia.
Tennant GB; Walsh V; Truran LN; Edwards P; Mills KI; Burnett AK
Br J Haematol; 2000 Dec; 111(3):853-62. PubMed ID: 11122147
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal culture from patients with myelodysplastic syndromes and patients at different stages of acute nonlymphocytic leukaemia.
Elstner E; Wächter M; Ihle R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):167-74. PubMed ID: 2472321
[TBL] [Abstract][Full Text] [Related]
12. Impaired clonogenic growth of myelodysplastic bone marrow progenitors in vitro is irrelevant to their apoptotic state.
Michalopoulou S; Micheva I; Kouraklis-Symeonidis A; Kakagianni T; Symeonidis A; Zoumbos NC
Leuk Res; 2004 Aug; 28(8):805-12. PubMed ID: 15203278
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
14. Effect of cA2 anti-tumor necrosis factor-alpha antibody therapy on hematopoiesis of patients with myelodysplastic syndromes.
Boula A; Voulgarelis M; Giannouli S; Katrinakis G; Psyllaki M; Pontikoglou C; Markidou F; Eliopoulos GD; Papadaki HA
Clin Cancer Res; 2006 May; 12(10):3099-108. PubMed ID: 16707608
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression.
Borojevic R; Roela RA; Rodarte RS; Thiago LS; Pasini FS; Conti FM; Rossi MI; Reis LF; Lopes LF; Brentani MM
Leuk Res; 2004 Aug; 28(8):831-44. PubMed ID: 15203281
[TBL] [Abstract][Full Text] [Related]
16. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
[TBL] [Abstract][Full Text] [Related]
17. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
18. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
[TBL] [Abstract][Full Text] [Related]
19. Impairment in immuno-modulatory function of Flk1(+)CD31(-)CD34(-) MSCs from MDS-RA patients.
Han Q; Sun Z; Liu L; Chen B; Cao Y; Li K; Zhao RC
Leuk Res; 2007 Nov; 31(11):1469-78. PubMed ID: 17360037
[TBL] [Abstract][Full Text] [Related]
20. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
